Concepedia

Publication | Open Access

Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis

DOIFull Paper Access

156

Citations

16

References

2014

Year

Sara Llufriú, María Sepúlveda, Yolanda Blanco, Beatriz Moreno, Iñigo Gabilondo, Eloy Martínez‐Heras, Núria Solà‐Valls, Joan-Albert Arnaiz, Enrique J. Andreu, Begoña Fernández,
PLoS ONE

Abstract

Bone-marrow-MSCs are safe and may reduce inflammatory MRI parameters supporting their immunomodulatory properties. ClinicalTrials.gov NCT01228266.

References

YearCitations

Page 1